Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael J. Dapp"'
Autor:
Michelle L. Christian, Michael J. Dapp, Samuel C. Scharffenberger, Hank Jones, Chaozhong Song, Lisa M. Frenkel, Anthony Krumm, James I. Mullins, David J. Rawlings
Publikováno v:
The Journal of Immunology. 208:1700-1710
One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (ISs) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same trans
Autor:
Michael J Dapp, Kord M Kober, Lennie Chen, Dylan H Westfall, Kim Wong, Hong Zhao, Breana M Hall, Wenjie Deng, Thomas Sibley, Suvankar Ghorai, Katie Kim, Natalie Chen, Sarah McHugh, Lily Au, Mardge Cohen, Kathryn Anastos, James I Mullins
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0182443 (2017)
Biological sex differences affect the course of HIV infection, with untreated women having lower viral loads compared to their male counterparts but, for a given viral load, women have a higher rate of progression to AIDS. However, the vast majority
Externí odkaz:
https://doaj.org/article/977db700df844816af228a3f9d60a525
Autor:
Michelle L, Christian, Michael J, Dapp, Samuel C, Scharffenberger, Hank, Jones, Chaozhong, Song, Lisa M, Frenkel, Anthony, Krumm, James I, Mullins, David J, Rawlings
Publikováno v:
J Immunol
One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (IS) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same transc
Autor:
Hong Zhao, Lily Au, Kathryn Anastos, Mardge H. Cohen, Lennie Chen, Kord M. Kober, Katie B. Kim, Kim G. Wong, Michael J. Dapp, Natalie Y. Chen, Suvankar Ghorai, Dylan H. Westfall, Thomas H. Sibley, Breana Hall, Sarah McHugh, Wenjie Deng, James I. Mullins
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0182443 (2017)
PloS one, vol 12, iss 10
PLoS ONE
PloS one, vol 12, iss 10
PLoS ONE
Biological sex differences affect the course of HIV infection, with untreated women having lower viral loads compared to their male counterparts but, for a given viral load, women have a higher rate of progression to AIDS. However, the vast majority
Publikováno v:
Journal of Virology. 88:354-363
Reverse transcription is an important early step in retrovirus replication and is a key point targeted by evolutionarily conserved host restriction factors (e.g., APOBEC3G, SamHD1). Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (R
Autor:
Louis M. Mansky, Jessica L. Martin, Michael J. Dapp, Richard H. Heineman, Steven E. Patterson, Erica Schnettler, Jonathan M.O. Rawson, Lauren B. Beach
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:7222-7228
The nucleoside analog 5,6-dihydro-5-aza-2'-deoxycytidine (KP-1212) has been investigated as a first-in-class lethal mutagen of human immunodeficiency virus type-1 (HIV-1). Since a prodrug monotherapy did not reduce viral loads in Phase II clinical tr
Publikováno v:
Trends in Microbiology. 21:56-62
The concept of eliminating HIV-1 infectivity by elevating the viral mutation rate was first proposed over a decade ago, even though the general concept had been conceived earlier for RNA viruses. Lethal mutagenesis was originally viewed as a novel ch
Publikováno v:
Journal of Molecular Biology. 425:41-53
Differences in replication fidelity, as well as mutator and antimutator strains, suggest that virus mutation rates are heritable and prone to natural selection. Human immunodeficiency virus type 1 (HIV-1) has many distinct advantages for the study of
Publikováno v:
Journal of Molecular Biology. 419:158-170
RNA virus population dynamics is complex, and sophisticated approaches are needed in many cases for therapeutic intervention. One such approach, termed lethal mutagenesis, is directed at targeting the virus population structure for extinction or erro
Publikováno v:
Journal of virology. 83(22)
Ribonucleosides inhibit human immunodeficiency virus type 1 (HIV-1) replication by mechanisms that have not been fully elucidated. Here, we report the antiviral mechanism for the ribonucleoside analog 5-azacytidine (5-AZC). We hypothesized that the a